title: Indocyanine green: photosensitizer or chromophore? Still a debate.
abstract: Indocyanine green (ICG) is a water-soluble anionic tricarbocyanine dye developed during the Second World War that was first approved for clinical use in humans in 1956. The main features of ICG that make it suitable for bioimaging applications are its near infrared absorption and its fluorescence. Although ICG is mainly used for its fluorescence emission properties, it has also been hypothesized that it can serve as a photosensitizer for photodynamic therapy applications, eliciting cytotoxic effects both in vitro and in vivo when used in combination with light at wavelengths in the region of 800-830 nm. Moreover, ICG can be used for hyperthermia of enhanced-photocoagulation of blood vessels treatment. In this paper we have gathered all the available data concerning the use of ICG for different treatments.
authors.forename: Camille
authors.initials: C
authors.lastname: Giraudeau
authors.forename: Albert
authors.initials: A
authors.lastname: Moussaron
authors.forename: Aurelie
authors.initials: A
authors.lastname: Stallivieri
authors.affiliation: INSERM U703, Institut Hippocrate 152, rue du Dr. Yersin, 59120 LOOS France. serge.mordon@inserm.fr.
authors.forename: Serge
authors.initials: S
authors.lastname: Mordon
authors.forename: Celine
authors.initials: C
authors.lastname: Frochot
mesh_terms: D000818:Animals; D006801:Humans; D007208:Indocyanine Green / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D017319:Photosensitizing Agents / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D017319:Photosensitizing Agents; D007208:Indocyanine Green